RITA Medical Systems Announces First Quarter 2006 Earnings Release Date and Conference Call
2006年4月14日 - 3:22AM
PRニュース・ワイアー (英語)
FREMONT, Calif., April 13 /PRNewswire-FirstCall/ -- RITA Medical
Systems, Inc. (NASDAQ:RITA) today announced that it will release
financial results for the first quarter ended March 31, 2006, after
the market close on Tuesday, May 9, 2006. The Company will also
host a conference call and webcast on Tuesday, May 9, 2006 at 2:00
p.m. Pacific Time to discuss the Company's first quarter results,
outlook for the remainder of 2006, and current corporate
developments. The dial-in number for the conference call is
800-240-5318 for domestic participants and 303-262-2130 for
international participants. A live webcast of the conference call
will also be available at http://www.ritamedical.com/. A taped
replay of the conference call will be available beginning
approximately one hour after the call's conclusion and will remain
available for 7 days. It can be accessed by dialing 800-405-2236
for domestic callers and 303-590-3000 for international callers,
both using the passcode 11058832#. Any financial or other
statistical information discussed during the call can be accessed
from the home page of RITA's website at
http://www.ritamedical.com/. In addition, an online replay of the
webcast will be available for one year immediately following the
broadcast by accessing the same link. Webcast participants are
encouraged to go to the site at least 15 minutes prior to the start
of the call to register, download and install any necessary audio
software. About RITA Medical Systems, Inc. RITA Medical Systems
develops, manufactures and markets innovative products for cancer
patients including radiofrequency ablation (RFA) systems for
treating cancerous tumors as well as percutaneous vascular and
spinal access systems. The Company's oncology product lines include
implantable ports, some of which feature its proprietary Vortex(R)
technology; tunneled central venous catheters; and safety infusion
sets and peripherally inserted central catheters used primarily in
cancer treatment protocols. The product line also includes the
HABIB 4X resection device which coagulates a surgical resection
plane and is designed to facilitate a fast dissection in order to
minimize blood loss and blood transfusion during surgery. The
proprietary RITA RFA system uses radiofrequency energy to heat
tissue to a high enough temperature to ablate it or cause cell
death. In March 2000, RITA became the first RFA Company to receive
specific FDA clearance for unresectable liver lesions in addition
to its previous general FDA clearance for the ablation of soft
tissue. In October 2002, RITA again became the first company to
receive specific FDA clearance, this time for the palliation of
pain associated with metastatic lesions involving bone. The RITA
Medical Systems website is at http://www.ritamedical.com/. The
Company cautions the reader that the planned appearances of Company
personnel, time and/or manner of the live teleconference, webcast
and replays may change for administrative or other reasons outside
the Company's control. DATASOURCE: RITA Medical Systems, Inc.
CONTACT: media, Steve DiMattia, +1-646-277-8706, or , or investors,
Doug Sherk, , or Jennifer Beugelmans, both at +1-415-896-6820, all
of EVC Group, for RITA; or Stephen Pedroff, VP Marketing of RITA
Medical Systems, Inc., +1-510-771-0400, or Web site:
http://www.ritamedical.com/
Copyright
Rita Medical (NASDAQ:RITA)
過去 株価チャート
から 5 2024 まで 6 2024
Rita Medical (NASDAQ:RITA)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Rita Medical Systems (ナスダック市場): 0 recent articles
その他のRita Medical Systems (MM)ニュース記事